© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 19, 1456-1462,
October 4, 1995
© 1995 Oxford University Press
Decreased Growth of Established Human Prostate LNCaP Tumors in Nude Mice Fed a Low-Fat Diet
Urology Service, Department of Surgery, Sloan-Kettering Institute for Cancer Research New York, NY
Urologic Oncology Research Laboratory, Section of Molecular Pharmacology and Therapeutics, Sloan-Kettering Institute for Cancer Research New York, NY
Department of Epidemology and Biostatistics, Memorial Sloan-Kettering Cancer Center.
*Correspondence to: Warren D. W. Heston, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Box 334, New York, NY 10021.
BACKGROUND:: Geographic variation in the incidence of clinically detected prostate cancer is considerable, with a 120-fold greater incidence in the United States than in China. The incidence of latent prostate cancer, however, shows little variation worldwide, with approximately 30% of men older than age 50 years having microfocal disease (determined by autopsy). Some epidemiologic studies have suggested that a high intake of dietary fat may constitute a risk factor for the development of advanced prostate cancer.
PURPOSE:: We studied the influence of dietary fat content on the growth of tumors established in athymic nude mice with androgen-sensitive, human prostatic adenocarcinoma cells (LNCaP cells). We also investigated whether manipulation of dietary fat content altered prostate-specific antigen (PSA) production by these tumors.
METHODS:: Tumors were induced in nude mice by subcutaneous injection of 106 LNCaP cells. Both the American Type Culture Collection (ATCC) LNCaP cell line and a more androgen-responsive subline derived from it (i.e., the Harris LNCaP cell line) were used. Mice were fed a 40.5-kcal% fat diet at the time of tumor cell injection. Three weeks later, after measurable tumors were formed, the animals were assigned to receive diets with one of the following fat contents: 40.5, 30.8, 21.2, 11.6, or 2.3 kcal% fat. Food intake, animal weights, and tumor volumes were recorded weekly; serum PSA and testosterone levels were measured at the termination of the study. Post hoc multiple comparisons were made using the Student-Newman-Keuls procedure. Two-sided tests of statistical significance were used to evaluate pairwise comparisons.
RESULTS:: Tumor growth rates, final tumor weights, and ratios of final tumor weights to animal weights were substantially greater in groups that continued to receive a 40.5-kcal% fat diet than in groups whose diets were changed to 2.3 kcal%, 11.6 kcal%, or 21.2 kcal% fat (all P values <.O4). Comparison of these parameters among the 2.3-kcal%, 11.6-kcal%, and 21.2-kcal% dietary fat groups did not reveal any statistically significant differences. No statistically significant differences were noted in total ingested calories, animal weight gain, serum testosterone levels, or histopathologic characteristics of the tumors among the tested dietary groups. Serum PSA levels were highest in the 40.5-kcal% fat group and lowest in the 2.3-kcal% fat group (evaluated only for ATCC LNCaP cells; P<.05).
CONCLUSIONS:: Reduction of dietary fat substantially slows the growth of tumors established from human prostatic adenocarcinoma cells in a murine xenograft model. A positive association persists between tumor volumes and serum PSA levels even after extreme modification of dietary fat content. [J Natl Cancer Inst 1995; 87: 1456–62]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Tamura, A. Makino, F. Hullin-Matsuda, T. Kobayashi, M. Furihata, S. Chung, S. Ashida, T. Miki, T. Fujioka, T. Shuin, et al. Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid Metabolism Cancer Res., October 15, 2009; 69(20): 8133 - 8140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Mavropoulos, W. C. Buschemeyer III, A. K. Tewari, D. Rokhfeld, M. Pollak, Y. Zhao, P. G. Febbo, P. Cohen, D. Hwang, G. Devi, et al. The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model Cancer Prevention Research, June 1, 2009; 2(6): 557 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Assinder, Q. Dong, H. Mangs, and D. R. Richardson Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-{beta} Pathways in Prostate Cancer Mol. Pharmacol., March 1, 2009; 75(3): 429 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kobayashi, R. J. Barnard, J. Said, J. Hong-Gonzalez, D. M. Corman, M. Ku, N. B. Doan, D. Gui, D. Elashoff, P. Cohen, et al. Effect of Low-Fat Diet on Development of Prostate Cancer and Akt Phosphorylation in the Hi-Myc Transgenic Mouse Model Cancer Res., April 15, 2008; 68(8): 3066 - 3073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Angelucci, S. Garofalo, S. Speca, A. Bovadilla, G. L. Gravina, P. Muzi, C. Vicentini, and M. Bologna Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells Endocr. Relat. Cancer, March 1, 2008; 15(1): 91 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R J. Barnard Prostate cancer prevention by nutritional means to alleviate metabolic syndrome Am. J. Clinical Nutrition, September 1, 2007; 86(3): 889S - 893S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Chavarro, M. J. Stampfer, H. Li, H. Campos, T. Kurth, and J. Ma A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Freedland Obesity and Prostate Cancer: A Growing Problem Clin. Cancer Res., October 1, 2005; 11(19): 6763 - 6766. [Full Text] [PDF]
|
|
|
|
|
|
T. H. Ngo, R. J. Barnard, T. Anton, C. Tran, D. Elashoff, D. Heber, S. J. Freedland, and W. J. Aronson Effect of Isocaloric Low-Fat Diet on Prostate Cancer Xenograft Progression to Androgen Independence Cancer Res., February 15, 2004; 64(4): 1252 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Freedland, W. J. Aronson, C. J. Kane, J. C. Presti Jr, C. L. Amling, D. Elashoff, and M. K. Terris Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group J. Clin. Oncol., February 1, 2004; 22(3): 446 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Ngo, R. J. Barnard, P. Cohen, S. Freedland, C. Tran, F. deGregorio, Y. I. Elshimali, D. Heber, and W. J. Aronson Effect of Isocaloric Low-fat Diet on Human LAPC-4 Prostate Cancer Xenografts in Severe Combined Immunodeficient Mice and the Insulin-like Growth Factor Axis Clin. Cancer Res., July 1, 2003; 9(7): 2734 - 2743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wilkinson and G. W. Chodak Critical Review of Complementary Therapies for Prostate Cancer J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shike, L. Latkany, E. Riedel, M. Fleisher, A. Schatzkin, E. Lanza, D. Corle, and C. B. Begg Lack of Effect of a Low-Fat, High-Fruit, -Vegetable, and -Fiber Diet on Serum Prostate-Specific Antigen of Men Without Prostate Cancer: Results From a Randomized Trial J. Clin. Oncol., September 1, 2002; 20(17): 3592 - 3598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tang, B. Bhatia, C. J. Maldonado, P. Yang, R. A. Newman, J. Liu, D. Chandra, J. Traag, R. D. Klein, S. M. Fischer, et al. Evidence That Arachidonate 15-Lipoxygenase 2 Is a Negative Cell Cycle Regulator in Normal Prostate Epithelial Cells J. Biol. Chem., May 3, 2002; 277(18): 16189 - 16201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Chung, S. H. Mitchell, J.-S. Zhang, and C. Y. F. Young Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells Carcinogenesis, August 1, 2001; 22(8): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Das, R. Hammamieh, R. Neill, M. Melhem, and M. Jett Expression Pattern of Fatty Acid-binding Proteins in Human Normal and Cancer Prostate Cells and Tissues Clin. Cancer Res., June 1, 2001; 7(6): 1706 - 1715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Pinto and R. S. Rivlin Antiproliferative Effects of Allium Derivatives from Garlic J. Nutr., March 1, 2001; 131(3): 1058S - 1060. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Sauer, R. T. Dauchy, and D. E. Blask Mechanism for the Antitumor and Anticachectic Effects of n-3 Fatty Acids Cancer Res., September 1, 2000; 60(18): 5289 - 5295. [Abstract] [Full Text]
|
|
|
|
|
|
A. B. Awad and C. S. Fink Phytosterols as Anticancer Dietary Components: Evidence and Mechanism of Action J. Nutr., September 1, 2000; 130(9): 2127 - 2130. [Abstract] [Full Text]
|
|
|
|
|
|
G. P. Collett, A. M. Betts, M. I. Johnson, A. B. Pulimood, S. Cook, D. E. Neal, and C. N. Robson Peroxisome Proliferator-activated Receptor {{alpha}} Is an Androgen-responsive Gene in Human Prostate and Is Highly Expressed in Prostatic Adenocarcinoma Clin. Cancer Res., August 1, 2000; 6(8): 3241 - 3248. [Abstract] [Full Text]
|
|
|
|
|
|
W. J. Wechter, D. D. Leipold, E. D. Murray Jr., D. Quiggle, J. D. McCracken, R. S. Barrios, and N. M. Greenberg E-7869 (R-Flurbiprofen) Inhibits Progression of Prostate Cancer in the TRAMP Mouse Cancer Res., April 1, 2000; 60(8): 2203 - 2208. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Butler, S. H. Mitchell, D. J. Tindall, and C. Y. F. Young Nonapoptotic Cell Death Associated with S-Phase Arrest of Prostate Cancer Cells via the Peroxisome Proliferator-activated Receptor {{gamma}} Ligand, 15-Deoxy-{{Delta}}12,14- prostaglandin J2 Cell Growth Differ., January 1, 2000; 11(1): 49 - 61. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Sauer, R. T. Dauchy, D. E. Blask, B. J. Armstrong, and S. Scalici 13-Hydroxyoctadecadienoic Acid Is the Mitogenic Signal for Linoleic Acid-dependent Growth in Rat Hepatoma 7288CTC in Vivo Cancer Res., September 1, 1999; 59(18): 4688 - 4692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Bosland, I. Oakley-Girvan, and A. S. Whittemore Dietary Fat, Calories, and Prostate Cancer Risk J Natl Cancer Inst, March 17, 1999; 91(6): 489 - 491. [Full Text] [PDF]
|
|
|
|
|
|
P. Mukherjee, A. V. Sotnikov, H. J. Mangian, J.-R. Zhou, W. J. Visek, and S. K. Clinton Energy Intake and Prostate Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Expression J Natl Cancer Inst, March 17, 1999; 91(6): 512 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Kolonel, A. M. Y. Nomura, and R. V. Cooney Dietary Fat and Prostate Cancer: Current Status J Natl Cancer Inst, March 3, 1999; 91(5): 414 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ghosh and C. E. Myers Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells PNAS, October 27, 1998; 95(22): 13182 - 13187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Sauer, R. T. Dauchy, and D. E. Blask Dietary Linoleic Acid Intake Controls the Arterial Blood Plasma Concentration and the Rates of Growth and Linoleic Acid Uptake and Metabolism in Hepatoma 7288CTC in Buffalo Rats J. Nutr., July 1, 1997; 127(7): 1412 - 1421. [Abstract] [Full Text]
|
|
|
|
|
|
S. K. Clinton, A. L. Mulloy, S. P. Li, H. J. Mangian, and W. J. Visek Dietary Fat and Protein Intake Differ in Modulation of Prostate Tumor Growth, Prolactin Secretion and Metabolism, and Prostate Gland Prolactin Binding Capacity in Rats J. Nutr., February 1, 1997; 127(2): 225 - 237. [Abstract] [Full Text]
|
|